Next Article in Journal
HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia
Previous Article in Journal
Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation
Previous Article in Special Issue
Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 13
Issue 2
10.3390/cancers13020242
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Personalized Medicine: Recent Progress in Cancer Therapy

by
Ann Hoeben
1,*,
Elbert A. J. Joosten
2 and
Marieke H. J. van den Beuken-van Everdingen
3
1
Department of Internal Medicine, Division of Medical Oncology, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
2
Department of Anesthesiology and Pain Management, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
3
Centre of Expertise for Palliative Care, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands
*
Author to whom correspondence should be addressed.
Cancers 2021, 13(2), 242; https://doi.org/10.3390/cancers13020242
Submission received: 2 December 2020 / Accepted: 23 December 2020 / Published: 11 January 2021
(This article belongs to the Special Issue Personalized Medicine: Recent Progress in Cancer Therapy)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Personalized medicine (PM) or precision medicine in oncology is an emerging approach for tumor treatment and prevention that takes into account inter- and intra-tumor variability in genes, tumor (immune) environment, and lifestyle and morbidities of each person diagnosed with cancer [...]

Share and Cite

MDPI and ACS Style

Hoeben, A.; Joosten, E.A.J.; van den Beuken-van Everdingen, M.H.J. Personalized Medicine: Recent Progress in Cancer Therapy. Cancers 2021, 13, 242. https://doi.org/10.3390/cancers13020242

AMA Style

Hoeben A, Joosten EAJ, van den Beuken-van Everdingen MHJ. Personalized Medicine: Recent Progress in Cancer Therapy. Cancers. 2021; 13(2):242. https://doi.org/10.3390/cancers13020242

Chicago/Turabian Style

Hoeben, Ann, Elbert A. J. Joosten, and Marieke H. J. van den Beuken-van Everdingen. 2021. "Personalized Medicine: Recent Progress in Cancer Therapy" Cancers 13, no. 2: 242. https://doi.org/10.3390/cancers13020242

APA Style

Hoeben, A., Joosten, E. A. J., & van den Beuken-van Everdingen, M. H. J. (2021). Personalized Medicine: Recent Progress in Cancer Therapy. Cancers, 13(2), 242. https://doi.org/10.3390/cancers13020242

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop